Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity

v3.8.0.1
Condensed Consolidated Statement of Changes in Stockholders' Equity - 9 months ended Sep. 30, 2017 - USD ($)
$ in Thousands
Total
Common Stock [Member]
Common Shares Issuable [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Non-Controlling Interests [Member]
Balance at Dec. 31, 2016 $ 82,968 $ 49 $ 0 $ 283,697 $ (245,251) $ 44,473
Balance (in shares) at Dec. 31, 2016   48,932,023        
Exercise of options for cash $ 27 $ 0 0 27 0 0
Exercise of options for cash (in shares) 20,000 20,000        
Stock-based compensation expense $ 12,048 $ 0 0 12,048 0 0
Issuance of restricted stock 0 $ 2 0 (2) 0 0
Issuance of restricted stock (in shares)   1,565,020        
Issuance of subsidiaries' common shares for license expenses 1,762 $ 0 0 1,762 0 0
Issuance of common stock under ESPP 42 $ 0 0 42 0 0
Issuance of common stock under ESPP (in shares)   22,076        
Subsidiaries' offering, net 94,645 $ 0 0 94,645 0 0
Debt discount related to Opus Credit Facility 201 0 0 201 0 0
Issuance of warrants by subsidiary in conjunction with NSC debt 750 0 0 750 0 0
Issuance of warrants in connection with 2017 promissory notes 1,784 0 0 1,784 0 0
Conversion of subsidiaries notes payable 314 0 0 314 0 0
Common shares issuable to NSC interest expense 353 0 353 0 0 0
Common shares issued to NSC interest expense 189 $ 0 0 189 0 0
Common shares issued to NSC interest expense (in shares)   45,818        
Non-controlling interest in subsidiaries' 0 $ 0 0 (57,203) 0 57,203
Net loss attributable to non-controlling interest (17,355) 0 0 0 0 (17,355)
Net loss attributable to common stockholders (56,463) 0 0 0 (56,463) 0
Balance at Sep. 30, 2017 $ 121,265 $ 51 $ 353 $ 338,254 $ (301,714) $ 84,321
Balance (in shares) at Sep. 30, 2017   50,584,937